Clinical Trial Update: An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

An open-label Phase 4 trial evaluated the efficacy of fesoterodine (Toviaz) after surgery for benign prostatic hyperplasia; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Bladder Outlet Obstruction

Drugs mentioned

• Toviaz (fesoterodine fumarate)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Bladder Outlet Obstruction | Phase 4 | Status: COMPLETED | Results posted: 2018-04-10